{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:39:43Z","timestamp":1783640383915,"version":"3.55.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02447-8","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T15:08:37Z","timestamp":1667833717000},"page":"707-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Overview of familial syndromes with increased skin malignancies"],"prefix":"10.1007","volume":"315","author":[{"given":"Hui Yu","family":"Juan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl M.","family":"Hoegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amor","family":"Khachemoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"2447_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","volume":"29","author":"R Gordon","year":"2013","unstructured":"Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29:160\u2013169","journal-title":"Semin Oncol Nurs"},{"key":"2447_CR2","doi-asserted-by":"crossref","unstructured":"Ma EZ, Zhou AE, Hoegler KM, Khachemoune A. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues. Arch Dermatol Res. 2022;","DOI":"10.1007\/s00403-022-02335-1"},{"key":"2447_CR3","volume-title":"Metastatic melanoma. StatPearls [Internet]","author":"S Sundararajan","year":"2022","unstructured":"Sundararajan S, Thida AM, Badri T (2022) Metastatic melanoma. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR4","unstructured":"Basal & Squamous Cell Skin Cancer Statistics [Internet]. https:\/\/www.cancer.org\/cancer\/basal-and-squamous-cell-skin-cancer\/about\/key-statistics.html. Accessed 9 Sep 2021"},{"key":"2447_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/bmj.327.7418.794","volume":"327","author":"CSM Wong","year":"2003","unstructured":"Wong CSM, Strange RC, Lear JT (2003) Basal cell carcinoma. BMJ 327:794\u2013798","journal-title":"BMJ"},{"key":"2447_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archderm.139.5.643","volume":"139","author":"JK Robinson","year":"2003","unstructured":"Robinson JK, Dahiya M (2003) Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 139:643\u2013648","journal-title":"Arch Dermatol"},{"key":"2447_CR7","unstructured":"Melanoma Skin Cancer Statistics [Internet]. https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html. Accessed 9 Sep 2021"},{"key":"2447_CR8","first-page":"167","volume":"88","author":"AG Marzuka","year":"2015","unstructured":"Marzuka AG, Book SE (2015) Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 88:167\u2013179","journal-title":"Yale J Biol Med"},{"key":"2447_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.hoc.2010.06.003","volume":"24","author":"MR Gerstenblith","year":"2010","unstructured":"Gerstenblith MR, Goldstein AM, Tucker MA (2010) Hereditary genodermatoses with cancer predisposition. Hematol Oncol Clin North Am 24:885\u2013906","journal-title":"Hematol Oncol Clin North Am"},{"key":"2447_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2340\/00015555-3123","volume":"99","author":"J Schierbeck","year":"2019","unstructured":"Schierbeck J, Vestergaard T, Bygum A (2019) Skin cancer associated genodermatoses: a literature review. Acta Derm Venereol 99:360\u2013369","journal-title":"Acta Derm Venereol"},{"key":"2447_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-2-43","volume":"2","author":"K Gr\u00f8nskov","year":"2007","unstructured":"Gr\u00f8nskov K, Ek J, Brondum-Nielsen K (2007) Oculocutaneous albinism. Orphanet J Rare Dis 2:43","journal-title":"Orphanet J Rare Dis"},{"key":"2447_CR12","unstructured":"[Mutations and polymorphisms of the P gene associated with oculocutaneous albinism type II] - PubMed [Internet]. https:\/\/pubmed.ncbi.nlm.nih.gov\/16378950\/. Accessed 10 Oct 2021"},{"key":"2447_CR13","first-page":"1005","volume":"10","author":"P Sundaresan","year":"2004","unstructured":"Sundaresan P, Sil AK, Philp AR, Randolph MA, Natchiar G, Namperumalsamy P (2004) Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: two novel frameshift mutations in the TYR Gene. Mol Vis 10:1005\u20131010","journal-title":"Mol Vis"},{"key":"2447_CR14","first-page":"984","volume":"27","author":"H-L Duan","year":"2005","unstructured":"Duan H-L, Zheng H (2005) Li H-Y [Mutations and polymorphisms of the P gene associated with oculocutaneous albinism type II]. Yi Chuan 27:984\u2013988","journal-title":"Yi Chuan"},{"key":"2447_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdermsci.2012.09.016","volume":"69","author":"JE Hawkes","year":"2013","unstructured":"Hawkes JE, Cassidy PB, Manga P, Boissy RE, Goldgar D, Cannon-Albright L et al (2013) Report of a novel OCA2 gene mutation and an investigation of two OCA2 variants on melanoma predisposition in a familial melanoma pedigree. J Dermatol Sci 69:30\u201337","journal-title":"J Dermatol Sci"},{"key":"2447_CR16","unstructured":"TYRP1\u2014an overview | ScienceDirect Topics [Internet]. https:\/\/www.sciencedirect.com\/topics\/biochemistry-genetics-and-molecular-biology\/tyrp1. Accessed 10 Oct 2021"},{"key":"2447_CR17","volume-title":"Albinism. StatPearls [Internet]","author":"JR Federico","year":"2022","unstructured":"Federico JR, Krishnamurthy K (2022) Albinism. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1477-7819-8-73","volume":"8","author":"KO Opara","year":"2010","unstructured":"Opara KO, Jiburum BC (2010) Skin cancers in albinos in a teaching Hospital in eastern Nigeria\u2014presentation and challenges of care. World J Surg Onc 8:73","journal-title":"World J Surg Onc"},{"key":"2447_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0027-5107(98)00182-1","volume":"422","author":"AJ Christophers","year":"1998","unstructured":"Christophers AJ (1998) Melanoma is not caused by sunlight. Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis 422:113\u2013117","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"2447_CR20","volume-title":"GeneReviews\u00ae [Internet]","author":"EG Pfendner","year":"1993","unstructured":"Pfendner EG, Lucky AW (1993) Dystrophic epidermolysis bullosa. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"J-D Fine","year":"2016","unstructured":"Fine J-D (2016) Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol 152:1231\u20131238","journal-title":"JAMA Dermatol"},{"key":"2447_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine J-D, Harper N, Has C et al (2020) Epidermolysis bullosa. Nat Rev Dis Primers 6:78","journal-title":"Nat Rev Dis Primers"},{"key":"2447_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/archderm.139.4.498","volume":"139","author":"D Ciubotaru","year":"2003","unstructured":"Ciubotaru D, Bergman R, Baty D, Indelman M, Pfendner E, Petronius D et al (2003) Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol 139:498\u2013505","journal-title":"Arch Dermatol"},{"key":"2447_CR24","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI38177","volume":"119","author":"PA Coulombe","year":"2009","unstructured":"Coulombe PA, Kerns ML, Fuchs E (2009) Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Invest 119:1784\u20131793","journal-title":"J Clin Invest"},{"key":"2447_CR25","unstructured":"OMIM Entry - # 131900\u2014epidermolysis bullosa simplex, generalized [Internet]. https:\/\/www.omim.org\/entry\/131900. Accessed 11 Oct 2021"},{"key":"2447_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/CCID.S54681","volume":"8","author":"S Shinkuma","year":"2015","unstructured":"Shinkuma S (2015) Dystrophic epidermolysis bullosa: a review. Clin Cosmet Investig Dermatol 8:275\u2013284","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2447_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.det.2009.10.006","volume":"28","author":"M Laimer","year":"2010","unstructured":"Laimer M, Lanschuetzer CM, Diem A, Bauer JW (2010) Herlitz junctional epidermolysis bullosa. Dermatol Clin 28:55\u201360","journal-title":"Dermatol Clin"},{"key":"2447_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.det.2009.10.008","volume":"28","author":"KB Yancey","year":"2010","unstructured":"Yancey KB, Hintner H (2010) Non-Herlitz junctional epidermolysis bullosa. Dermatol Clin 28:67\u201377","journal-title":"Dermatol Clin"},{"key":"2447_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00439-001-0630-1","volume":"110","author":"A Nakano","year":"2002","unstructured":"Nakano A, Chao S-C, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfendner E et al (2002) Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes. Hum Genet 110:41\u201351","journal-title":"Hum Genet"},{"key":"2447_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/hmg\/5.2.231","volume":"5","author":"S Kivirikko","year":"1996","unstructured":"Kivirikko S, McGrath JA, Pulkkinen L, Uitto J, Christiano AM (1996) Mutational hotspots in the LAMB3 gene in the Lethal (Herlitz) type of junctional epidermolysis bullosa. Hum Mol Genet 5:231\u2013237","journal-title":"Hum Mol Genet"},{"key":"2447_CR31","volume-title":"GeneReviews\u00ae [Internet]","author":"L Youssefian","year":"1993","unstructured":"Youssefian L, Vahidnezhad H, Uitto J (1993) Kindler syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.det.2009.10.013","volume":"28","author":"JE Lai-Cheong","year":"2010","unstructured":"Lai-Cheong JE, McGrath JA (2010) Kindler syndrome. Dermatol Clin 28:119\u2013124","journal-title":"Dermatol Clin"},{"key":"2447_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/hmg\/ddg097","volume":"12","author":"F Jobard","year":"2003","unstructured":"Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, Matsuda F et al (2003) Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet 12:925\u2013935","journal-title":"Hum Mol Genet"},{"key":"2447_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/humu.21576","volume":"32","author":"C Has","year":"2011","unstructured":"Has C, Castiglia D, del Rio M, Diez MG, Piccinni E, Kiritsi D et al (2011) Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum Mutat 32:1204\u20131212","journal-title":"Hum Mutat"},{"key":"2447_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00508-016-1133-3","volume":"129","author":"M Laimer","year":"2017","unstructured":"Laimer M, Pohla-Gubo G, Diem A, Prodinger C, Bauer JW, Hintner H (2017) Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network. Wien Klin Wochenschr 129:1\u20137","journal-title":"Wien Klin Wochenschr"},{"key":"2447_CR36","volume-title":"GeneReviews\u00ae [Internet]","author":"EG Pfendner","year":"1993","unstructured":"Pfendner EG, Lucky AW (1993) Junctional epidermolysis bullosa. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","volume":"11","author":"H Montaudi\u00e9","year":"2016","unstructured":"Montaudi\u00e9 H, Chiaverini C, Sbidian E, Charlesworth A, Lacour J-P (2016) Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis 11:117","journal-title":"Orphanet J Rare Dis"},{"key":"2447_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s40257-021-00626-3","volume":"22","author":"P-C Hou","year":"2021","unstructured":"Hou P-C, Wang H-T, Abhee S, Tu W-T, McGrath JA, Hsu C-K (2021) Investigational treatments for epidermolysis bullosa. Am J Clin Dermatol 22:801\u2013817","journal-title":"Am J Clin Dermatol"},{"key":"2447_CR39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2012.01.016","volume":"67","author":"E Pope","year":"2012","unstructured":"Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R et al (2012) A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 67:904\u2013917","journal-title":"J Am Acad Dermatol"},{"key":"2447_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000356068","volume":"45","author":"B Burger","year":"2014","unstructured":"Burger B, Itin PH (2014) Epidermodysplasia verruciformis. Curr Probl Dermatol 45:123\u2013131","journal-title":"Curr Probl Dermatol"},{"key":"2447_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaad.2015.08.073","volume":"74","author":"PD Jaju","year":"2016","unstructured":"Jaju PD, Ransohoff KJ, Tang JY, Sarin KY (2016) Familial skin cancer syndromes: increased risk of nonmelanotic skin cancers and extracutaneous tumors. J Am Acad Dermatol. 74:437\u2013451 (quiz 452\u20134)","journal-title":"J Am Acad Dermatol."},{"key":"2447_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2006.08.013","volume":"44","author":"Y-G Zuo","year":"2006","unstructured":"Zuo Y-G, Ma D, Zhang Y, Qiao J, Wang B (2006) Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 44:153\u2013159","journal-title":"J Dermatol Sci"},{"key":"2447_CR43","volume-title":"Epidermodysplasia verruciformis. StatPearls [Internet]","author":"DJ Myers","year":"2022","unstructured":"Myers DJ, Kwan E, Fillman EP (2022) Epidermodysplasia verruciformis. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-5945-14-12","volume":"14","author":"R Yoshida","year":"2014","unstructured":"Yoshida R, Kato T, Kawase M, Honda M, Mitsuishi T (2014) Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report. BMC Dermatol 14:12","journal-title":"BMC Dermatol"},{"key":"2447_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/BF00412621","volume":"279","author":"PC van Voorst Vader","year":"1987","unstructured":"van Voorst Vader PC, de Jong MC, Blanken R, Kallenberg CG, Vermey A, Scheres JM (1987) Epidermodysplasia verruciformis: langerhans cells, immunologic effect of retinoid treatment and cytogenetics. Arch Dermatol Res 279:366\u2013373","journal-title":"Arch Dermatol Res"},{"key":"2447_CR46","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/genes11121410","volume":"11","author":"D Goudie","year":"2020","unstructured":"Goudie D (2020) Multiple self-healing squamous epithelioma (MSSE): a digenic trait associated with loss of function mutations in TGFBR1 and variants at a second linked locus on the long arm of chromosome 9. Genes (Basel) 11:1410","journal-title":"Genes (Basel)"},{"key":"2447_CR47","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/jid.2013.45","volume":"133","author":"HC Kang","year":"2013","unstructured":"Kang HC, Quigley DA, Kim I-J, Wakabayashi Y, Ferguson-Smith MA, D\u2019Alessandro M et al (2013) Multiple Self-Healing Squamous Epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology. J Invest Dermatol 133:1907\u20131910","journal-title":"J Invest Dermatol"},{"key":"2447_CR48","unstructured":"Multiple self-healing squamous epithelioma [Internet]. http:\/\/documents.irevues.inist.fr\/handle\/2042\/44572. Accessed 17 Oct 2021"},{"key":"2447_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1086\/302718","volume":"66","author":"Y-A Lee","year":"2000","unstructured":"Lee Y-A, Stevens HP, Delaporte E, Wahn U, Reis A (2000) A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez Syndrome) maps to chromosome 4q23. Am J Hum Genet 66:326\u2013330","journal-title":"Am J Hum Genet"},{"key":"2447_CR50","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jid.2018.01.015","volume":"138","author":"C G\u00fcnther","year":"2018","unstructured":"G\u00fcnther C, Lee-Kirsch MA, Eckhard J, Matanovic A, Kerscher T, R\u00fcschendorf F et al (2018) SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility. J Invest Dermatol 138:1428\u20131431","journal-title":"J Invest Dermatol"},{"key":"2447_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000479036","volume":"4","author":"NS \u00c7elik","year":"2018","unstructured":"\u00c7elik NS, Ya\u015far \u015e, Aytekin S, G\u00fcne\u015f P (2018) A rare syndrome resembling scleroderma: Huriez syndrome. Skin Appendage Disord 4:82\u201385","journal-title":"Skin Appendage Disord"},{"key":"2447_CR52","volume-title":"Fanconi anemia. StatPearls [Internet]","author":"J Bhandari","year":"2022","unstructured":"Bhandari J, Thada PK, Puckett Y (2022) Fanconi anemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mrfmmm.2013.01.001","volume":"0","author":"LE Romick-Rosendale","year":"2013","unstructured":"Romick-Rosendale LE, Lui VWY, Grandis JR, Wells SI (2013) The fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res. 0:78\u201388","journal-title":"Mutat Res."},{"key":"2447_CR54","volume-title":"GeneReviews\u00ae [Internet]","author":"LL Wang","year":"1993","unstructured":"Wang LL, Plon SE (1993) Rothmund-Thomson syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.570084","volume":"8","author":"R Sharma","year":"2020","unstructured":"Sharma R, Lewis S, Wlodarski MW (2020) DNA repair syndromes and cancer: insights into genetics and phenotype patterns. Front Pediatr 8:570084","journal-title":"Front Pediatr"},{"key":"2447_CR56","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/ijd.12408","volume":"53","author":"H Arora","year":"2014","unstructured":"Arora H, Chacon AH, Choudhary S, McLeod MP, Meshkov L, Nouri K et al (2014) Bloom syndrome. Int J Dermatol 53:798\u2013802","journal-title":"Int J Dermatol"},{"key":"2447_CR57","volume-title":"Bloom syndrome. StatPearls [Internet]","author":"W Hafsi","year":"2022","unstructured":"Hafsi W, Badri T, Rice AS (2022) Bloom syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000452082","volume":"8","author":"C Cunniff","year":"2017","unstructured":"Cunniff C, Bassetti JA, Ellis NA (2017) Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Mol Syndromol 8:4\u201323","journal-title":"Mol Syndromol"},{"key":"2447_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","volume":"33","author":"J Oshima","year":"2017","unstructured":"Oshima J, Sidorova JM, Monnat RJ (2017) Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev 33:105\u2013114","journal-title":"Ageing Res Rev"},{"key":"2447_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","volume":"23","author":"SA Savage","year":"2009","unstructured":"Savage SA, Alter BP (2009) Dyskeratosis congenita. Hematol Oncol Clin N Am 23:215\u2013231","journal-title":"Hematol Oncol Clin N Am"},{"key":"2447_CR61","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cancergen.2011.11.002","volume":"204","author":"PJ Mason","year":"2011","unstructured":"Mason PJ, Bessler M (2011) The genetics of dyskeratosis congenita. Cancer Genet 204:635\u2013645","journal-title":"Cancer Genet"},{"key":"2447_CR62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s000180300042","volume":"60","author":"A Marrone","year":"2003","unstructured":"Marrone A, Mason PJ (2003) Human genome and diseases: dyskeratosis congenita. CMLS Cell Mol Life Sci 60:507\u2013517","journal-title":"CMLS Cell Mol Life Sci"},{"key":"2447_CR63","volume-title":"GeneReviews\u00ae [Internet]","author":"SA Savage","year":"1993","unstructured":"Savage SA, Niewisch MR (1993) Dyskeratosis congenita and related telomere biology disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR64","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.mayocp.2019.04.032","volume":"94","author":"ET Stoopler","year":"2019","unstructured":"Stoopler ET, Shanti RM (2019) Dyskeratosis congenita. Mayo Clin Proc 94:1668\u20131669","journal-title":"Mayo Clin Proc"},{"key":"2447_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12881-018-0584-y","volume":"19","author":"V Ratnasamy","year":"2018","unstructured":"Ratnasamy V, Navaneethakrishnan S, Sirisena ND, Gr\u00fcning N-M, Brandau O, Thirunavukarasu K et al (2018) Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report. BMC Med Genet 19:85","journal-title":"BMC Med Genet"},{"key":"2447_CR66","first-page":"157","volume":"5","author":"MS Fern\u00e1ndez Garc\u00eda","year":"2014","unstructured":"Fern\u00e1ndez Garc\u00eda MS, Teruya-Feldstein J (2014) The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med 5:157\u2013167","journal-title":"J Blood Med"},{"key":"2447_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.soc.2008.08.003","volume":"18","author":"AA Santillan","year":"2009","unstructured":"Santillan AA, Cherpelis BS, Glass LF, Sondak VK (2009) Management of familial melanoma and nonmelanoma skin cancer syndromes. Surg Oncol Clin N Am 18:73\u201398 (viii)","journal-title":"Surg Oncol Clin N Am"},{"key":"2447_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15884","author":"LT Fern\u00e1ndez","year":"2022","unstructured":"Fern\u00e1ndez LT, Ocampo-Garza SS, Elizondo-Riojas G, Ocampo-Candiani J (2022) Basal cell nevus syndrome: an update on clinical findings. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.15884","journal-title":"Int J Dermatol"},{"key":"2447_CR69","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1158\/0008-5472.CAN-14-1666","volume":"74","author":"M Athar","year":"2014","unstructured":"Athar M, Li C, Kim AL, Spiegelman VS, Bickers DR (2014) Sonic hedgehog signaling in Basal cell nevus syndrome. Cancer Res 74:4967\u20134975","journal-title":"Cancer Res"},{"key":"2447_CR70","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5114\/ada.2017.69323","volume":"34","author":"H Witmanowski","year":"2017","unstructured":"Witmanowski H, Szychta P, B\u0142ochowiak K, Jundzi\u0142\u0142 A, Czajkowski R (2017) Basal cell nevus syndrome (Gorlin-Goltz syndrome): genetic predisposition, clinical picture and treatment. Postepy Dermatol Alergol 34:381\u2013387","journal-title":"Postepy Dermatol Alergol"},{"key":"2447_CR71","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/modpathol.3800512","volume":"19","author":"AN Crowson","year":"2006","unstructured":"Crowson AN (2006) Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19:S127\u2013S147","journal-title":"Mod Pathol"},{"key":"2447_CR72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.14206","volume":"174","author":"AM John","year":"2016","unstructured":"John AM, Schwartz RA (2016) Basal cell naevus syndrome: an update on genetics and treatment. Br J Dermatol 174:68\u201376","journal-title":"Br J Dermatol"},{"key":"2447_CR73","volume-title":"Acrokeratosis paraneoplastica. StatPearls [Internet]","author":"JK Pulickal","year":"2022","unstructured":"Pulickal JK, Kaliyadan F (2022) Acrokeratosis paraneoplastica. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02054-9","volume":"4","author":"H-S Park","year":"2021","unstructured":"Park H-S, Papanastasi E, Blanchard G, Chiticariu E, Bachmann D, Plomann M et al (2021) ARP-T1-associated Bazex\u2013Dupr\u00e9\u2013Christol syndrome is an inherited basal cell cancer with ciliary defects characteristic of ciliopathies. Commun Biol 4:1\u201313","journal-title":"Commun Biol"},{"key":"2447_CR75","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmg.2008.12.003","volume":"52","author":"M Castori","year":"2009","unstructured":"Castori M, Castiglia D, Passarelli F, Paradisi M (2009) Bazex-Dupr\u00e9-Christol syndrome: an ectodermal dysplasia with skin appendage neoplasms. Eur J Med Genet 52:250\u2013255","journal-title":"Eur J Med Genet"},{"key":"2447_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/2229-5178.105456","volume":"4","author":"LA Dourmishev","year":"2013","unstructured":"Dourmishev LA, Rusinova D, Botev I (2013) Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J 4:12\u201317","journal-title":"Indian Dermatol Online J"},{"key":"2447_CR77","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/jdv.14199","volume":"31","author":"F R\u00e4\u00dfler","year":"2017","unstructured":"R\u00e4\u00dfler F, Goetze S, Elsner P (2017) Acrokeratosis paraneoplastica (Bazex syndrome) - a systematic review on risk factors, diagnosis, prognosis and management. J Eur Acad Dermatol Venereol 31:1119\u20131136","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2447_CR78","doi-asserted-by":"publisher","unstructured":"Zhou AE, Hoegler KM, Solimine JF (2021) Genetic counseling and testing for hereditary causes of melanoma can lead to earlier detection of skin cancer and other malignancies. Int J Dermatol\nijd 15716. https:\/\/doi.org\/10.1111\/ijd.15716","DOI":"10.1111\/ijd.15716"},{"key":"2447_CR79","volume-title":"Cancer syndromes [Internet]","author":"D Eckerle Mize","year":"2022","unstructured":"Eckerle Mize D, Bishop M, Resse E, Sluzevich J (2022) Familial atypical multiple mole melanoma syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M (eds) Cancer syndromes [Internet]. National Center for Biotechnology Information, Bethesda"},{"key":"2447_CR80","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","volume":"74","author":"E Soura","year":"2016","unstructured":"Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H (2016) Hereditary melanoma: Update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 74:395\u2013407 (quiz 408\u201310)","journal-title":"J Am Acad Dermatol."},{"key":"2447_CR81","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1590\/S1807-59322011000300023","volume":"66","author":"JH Silva","year":"2011","unstructured":"Silva JH, de S\u00e1 BCS, de \u00c1vila ALR, Landman G, Neto JPD (2011) Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma\u2014review article. Clinics (Sao Paulo) 66:493\u2013499","journal-title":"Clinics (Sao Paulo)"},{"key":"2447_CR82","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.currproblcancer.2011.07.001","volume":"35","author":"DC Bonadies","year":"2011","unstructured":"Bonadies DC, Bale AE (2011) Hereditary melanoma. Curr Probl Cancer 35:162\u2013172","journal-title":"Curr Probl Cancer"},{"key":"2447_CR83","volume-title":"GeneReviews\u00ae [Internet]","author":"N Petrucelli","year":"1993","unstructured":"Petrucelli N, Daly MB, Pal T (1993) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR84","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41467-017-00921-w","volume":"8","author":"N Riaz","year":"2017","unstructured":"Riaz N, Blecua P, Lim RS, Shen R, Higginson DS, Weinhold N et al (2017) Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes. Nat Commun 8:857","journal-title":"Nat Commun"},{"key":"2447_CR85","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/bjd.13626","volume":"172","author":"PV Gumaste","year":"2015","unstructured":"Gumaste PV, Penn LA, Cymerman RM, Kirchhoff T, Polsky D, McLellan B (2015) Skin cancer risk in BRCA1\/2 mutation carriers. Br J Dermatol 172:1498\u20131506","journal-title":"Br J Dermatol"},{"key":"2447_CR86","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","unstructured":"Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310\u20131316","journal-title":"J Natl Cancer Inst"},{"key":"2447_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM et al (2021) Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Comprehensive Cancer Netw 19:77\u2013102","journal-title":"J Natl Comprehensive Cancer Netw"},{"key":"2447_CR88","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ (2019) Current state of melanoma diagnosis and treatment. Cancer Biol Ther 20:1366\u20131379","journal-title":"Cancer Biol Ther"},{"key":"2447_CR89","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cge.12630","volume":"89","author":"K Rai","year":"2016","unstructured":"Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH (2016) Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet 89:285\u2013294","journal-title":"Clin Genet"},{"key":"2447_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG et al (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10:179","journal-title":"J Transl Med"},{"key":"2447_CR91","volume-title":"GeneReviews\u00ae [Internet]","author":"R Pilarski","year":"1993","unstructured":"Pilarski R, Carlo MI, Cebulla C, Abdel-Rahman M (1993) BAP1 tumor predisposition syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle (WA)"},{"key":"2447_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","volume":"10","author":"JO Black","year":"2016","unstructured":"Black JO (2016) Xeroderma pigmentosum. Head Neck Pathol 10:139\u2013144","journal-title":"Head Neck Pathol"},{"key":"2447_CR93","volume-title":"GeneReviews\u00ae [Internet]","author":"KH Kraemer","year":"1993","unstructured":"Kraemer KH, DiGiovanna JJ, Tamura D (1993) Xeroderma pigmentosum. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR94","volume-title":"Xeroderma pigmentosum. StatPearls [Internet]","author":"R Lucero","year":"2022","unstructured":"Lucero R, Horowitz D (2022) Xeroderma pigmentosum. StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"2447_CR95","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1757-1626-1-254","volume":"1","author":"J Halpern","year":"2008","unstructured":"Halpern J, Hopping B, Brostoff JM (2008) Photosensitivity, corneal scarring and developmental delay: xeroderma pigmentosum in a tropical country. Cases J 1:254","journal-title":"Cases J"},{"key":"2447_CR96","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jmg.2010.083022","volume":"48","author":"PT Bradford","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J et al (2011) Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterizes the role of dna repair. J Med Genet 48:168\u2013176","journal-title":"J Med Genet"},{"key":"2447_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0300-9084(01)01361-X","volume":"84","author":"A Chompret","year":"2002","unstructured":"Chompret A (2002) The Li-Fraumeni syndrome. Biochimie 84:75\u201382","journal-title":"Biochimie"},{"key":"2447_CR98","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10689-020-00178-1","volume":"19","author":"SA Nieuwenburg","year":"2020","unstructured":"Nieuwenburg SA, Adan F, Ruijs MWG, Sonke GS, van Leerdam ME, Crijns MB (2020) Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome. Fam Cancer 19:347\u2013351","journal-title":"Fam Cancer"},{"key":"2447_CR99","volume-title":"GeneReviews\u00ae [Internet]","author":"K Schneider","year":"1993","unstructured":"Schneider K, Zelley K, Nichols KE, Garber J (1993) Li-Fraumeni Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"2447_CR100","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.jid.2022.02.004","volume":"142","author":"JN Hatton","year":"2022","unstructured":"Hatton JN, Sargen MR, Frone MN, de Andrade KC, Savage SA, Khincha PP (2022) Spectrum and incidence of skin cancer among individuals with Li-Fraumeni syndrome. J Invest Dermatol 142:2534-2537.e1. https:\/\/doi.org\/10.1016\/j.jid.2022.02.004","journal-title":"J Invest Dermatol"},{"key":"2447_CR101","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bjd.19384","volume":"184","author":"FP-C Chiu","year":"2021","unstructured":"Chiu FP-C, Doolan BJ, McGrath JA, Onoufriadis A (2021) A decade of next-generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics. Br J Dermatol 184:606\u2013616","journal-title":"Br J Dermatol"},{"key":"2447_CR102","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4103\/ijd.IJD_323_20","volume":"65","author":"T Sarkar","year":"2020","unstructured":"Sarkar T, Sarkar S, Gangopadhyay DN (2020) Gene therapy and its application in dermatology. Indian J Dermatol 65:341\u2013350","journal-title":"Indian J Dermatol"},{"key":"2447_CR103","doi-asserted-by":"publisher","first-page":"281","DOI":"10.12688\/f1000research.23185.1","volume":"9","author":"C Baker","year":"2020","unstructured":"Baker C, Hayden MS (2020) Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease. F1000Res 9:281","journal-title":"F1000Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02447-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T12:03:19Z","timestamp":1681128199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":103,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02447-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}